Preclinical Assessment of Dual CYP26[A1/B1] Inhibitor, DX308, as an Improved Treatment for Keratinization Disorders is a research paper published in Skin Health and Disease (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R44AR069416
National Institute of Health
Grant: P20GM103546
Northwestern University Skin Biology and Diseases Resource-based Center
Grant: P30AR075049
National Institutes of Health
Grant: 5P20GM103546-09
Biomolecular Structure and Dynamics
National Institutes of Health
Grant: 1P30AR075049-01
Northwestern University Skin Biology and Diseases Resource-based Center
National Institutes of Health
Grant: 3R44AR069416-02S1
Selective inhibition of CYP26A1 in the skin for the treatment of ichthyosis
National Institute of Arthritis and Musculoskeletal and Skin Disease
FWCI
0.15
Citation Percentile
0.4%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals